Comparing three catheter treatments for acute pulmonary embolism
This trial tests three ways of using a catheter (a thin tube) to remove or break up blood clots in the lungs for people with a serious but stable type of pulmonary embolism. The goal is to find the best approach to improve recovery and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with a pulmonary embolism (blood clot in the lungs) within the last 14 days.
- Your blood clot is large enough to be seen in the main lung arteries on a CT scan.
- You have signs that your heart is working harder due to the clot, such as elevated troponin (a heart protein) or heart strain on imaging.
- You are not eligible for or did not respond to clot-dissolving medicine, or you got worse while on blood thinners.
- You must be able to give informed consent and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This trial tests two ways to treat a serious blood clot in the lungs: removing the clot with a small tube (catheter) alone, or combining that with a low dose of clot-dissolving medicine. The goal is to find a safer and effective treatment for people who can't have standard clot-busting treatment.
This study compares two ways to treat a serious pulmonary embolism (a blood clot in the lungs): using clot-busting medicine delivered through an IV, or using a catheter (a thin tube) to guide treatment directly to the clot. The goal is to find which approach works better and is safer for people at intermediate-high risk.
This study looks at how well a catheter (a thin tube) works to treat a serious type of blood clot in the lungs. It is for people who have a large clot that is causing problems like fast heart rate or low blood pressure.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This trial compares three treatments for an intermediate-high risk pulmonary embolism: a minimally invasive clot removal procedure (embolectomy), a low-dose clot-dissolving medication, or standard blood thinning (heparin). The goal is to see which approach works best to prevent worsening while reducing bleeding risks.
Hear when a new Acute Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.